Q3 Financial Results 2025-26

AI SummaryClose X

Beximco Pharmaceuticals PLC reported strong financial results for the nine months ended March 31, 2026, with net sales increasing by 13.1% to BDT 41,428.0m (£256.9m), driven by a 14.4% rise in domestic sales, although export sales saw a slight decrease of 1.2%. Profit after tax surged by 34.0% to BDT 7,048.6m (£43.7m) for the same period. The third quarter also showed positive growth, with net sales up 8.1% to BDT 13,627.8m (£84.5m) and profit after tax increasing by 30.6% to BDT 2,254.4m (£14.0m).

Disclaimer*

UK 100

Latest directors dealings